7.74
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Ardelyx Inc Borsa (ARDX) Ultime notizie
Ardelyx’s Stock Ascends Following Strategic Upgrades and Promising Revenue Projections - StocksToTrade
Why Ardelyx (ARDX) Is Up 20.1% After Lawsuit Dismissal And Patent Extension For Tenapanor - simplywall.st
Ardelyx upgraded at Piper Sandler on Ibsrela (ARDX:NASDAQ) - Seeking Alpha
Assessing Ardelyx (ARDX) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
ARDX Analyst Upgrade: Citigroup Raises Price Target to $14.00 | ARDX Stock News - GuruFocus
Ardelyx Surges Following Analysts’ Bold Price Target Upgrades - timothysykes.com
American Airlines To Rally More Than 27%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Ardelyx Stock Rises Premarket As Piper Sees Over 100% Upside — Says Constipation Drug ‘Stole The Show’ With 2026 Guidance - Asianet Newsable
Why The Ardelyx ARDX Story Is Shifting On New Ibsrela Targets And Valuation Assumptions - Yahoo Finance
BTIG Raises Ardelyx (ARDX) Price Target to $17 and Maintains Buy Rating | ARDX Stock News - GuruFocus
Ardelyx stock rises premarket as Piper sees over 100% upside — says constipation drug 'stole the show' with 2026 guidance - MSN
Ardelyx stock price target raised to $17 from $14 at BTIG on strong Ibsrela sales - Investing.com Australia
Ardelyx Inc: Piper Sandler raises to overweight from neutral; raises target price to $16 from $10 - MarketScreener
What hedge fund moves indicate for Ardelyx Inc. (41X) stock2025 Sector Review & Weekly High Return Opportunities - ulpravda.ru
Ardelyx stock price target raised to $19 from $16 at Raymond James - Investing.com
How Ardelyx Inc. (41X) stock reacts to fiscal policies2025 Key Lessons & Weekly Momentum Picks - ulpravda.ru
Wall Street analysts see a 92.12% upside in Ardelyx (ARDX): Can the stock really move this high? - MSN
Why hedge funds are buying Ardelyx Inc. stockLayoff News & Daily Oversold Stock Bounce Ideas - ulpravda.ru
Ardelyx Stock Is Rallying – What Is Making Retail So Bullish? - Stocktwits
Ardelyx Stock Climbs Amid Revised Financial Outlook and Strategic Expansion - timothysykes.com
Why Ardelyx Inc. stock remains a top recommendation2025 EndofYear Setup & Risk Managed Investment Entry Signals - ulpravda.ru
Ardelyx stock hits 52-week high at 6.79 USD By Investing.com - Investing.com Canada
Ardelyx (ARDX) Projects Significant Revenue Growth for IBSRELA i - GuruFocus
Ardelyx stock hits 52-week high at 6.79 USD - Investing.com
Can Ardelyx Inc. (41X) stock sustain institutional flowsJobs Report & Technical Analysis for Trade Confirmation - ulpravda.ru
Is Ardelyx Inc. stock vulnerable to regulatory risksJuly 2025 Market Mood & Daily Growth Stock Tips - ulpravda.ru
Ardelyx stock rises after reporting strong 2025 revenue, upbeat 2026 outlook By Investing.com - Investing.com South Africa
Assessing Ardelyx (ARDX) Valuation After Mixed Long Term Shareholder Returns - simplywall.st
Ardelyx stock rises after reporting strong 2025 revenue, upbeat 2026 outlook - Investing.com Canada
Ardelyx reports preliminary 2025 revenue and provides 2026 strategic outlook - MarketScreener
ARDX Sees Significant Revenue Growth in 2025 - GuruFocus
Ardelyx files procedural regulatory disclosure update notice - TipRanks
Ardelyx Provides 2026 Revenue Guidance for Ibsrela, Xphozah - MarketScreener
Ardelyx Reports Preliminary 2025 Revenue And Provides 2026 Strategic Outlook - TradingView — Track All Markets
Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook - The Manila Times
Constipation pill IBSRELA targets $1B in yearly sales by 2029 - Stock Titan
Long road gets longer for Ardelyx, with hope on the horizon - The Pharma Letter
Ardelyx rises amid report on price hikes for lead product - MSN
Wall Street Analysts See a 92.12% Upside in Ardelyx (ARDX): Can the Stock Really Move This High? - sharewise.com
Ardelyx Stock Rises After-Hours On Q4 Beat, Drug Sales Outlook: Retail Gets Big Dose Of Optimism - MSN
How Ardelyx Inc. (41X) stock reacts to weak economy2026 world cup usa national team semifinals key players high defensive line winner prediction tactical review - ulpravda.ru
Ardelyx (NASDAQ:ARDX) Shares Down 6.9%Here's Why - MarketBeat
Ardelyx (ARDX) Moves 5.5% Higher: Will This Strength Last? - Yahoo Finance
Ardelyx (ARDX) Meets Q4 Earnings Estimates - MSN
Ardelyx Stock Gains Momentum After Positive Developments - StocksToTrade
Key Developments Shaping Ardelyx’s Financial Journey - timothysykes.com
When Does Changing Course Become Securities Fraud? Court Rules Against Ardelyx Shareholders - TipRanks
Ardelyx stock jumps as Raymond James notes price hikes By Investing.com - Investing.com Australia
Ardelyx Shares Surge Following Strategic Clinical Update - timothysykes.com
Ardelyx Stock Rises Amid Market Developments - timothysykes.com
Ardelyx (ARDX) Boosts Product Prices, Shares Climb - GuruFocus
Raymond James reiterates Strong Buy on Ardelyx stock after price increases - Investing.com Nigeria
Raymond James reiterates Strong Buy on Ardelyx stock after price increases By Investing.com - Investing.com South Africa
Ardelyx stock jumps as Raymond James notes price hikes - Investing.com
Ardelyx gains on price hikes for lead product (ARDX:NASDAQ) - Seeking Alpha
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):